Search
An international clinical trial led by The Kids Research Institute Australia Cancer Centre is trialling a drug which could increase cure rates for aggressive forms of childhood brain cancer.
The ORIGINS Project, a collaboration between The Kids and Joondalup Health Campus, is collecting data and biological samples from 10,000 families over 10 years. Its work is also giving participating families a valuable heads up on health issues.
A program unfolding in four very diverse locations across Western Australia is working to give children aged 0–4 the best start in life.
Strong advocacy efforts have paid off with health and food safety ministers from around Australia and New Zealand finally approving the recommended version of a warning label designed to highlight the potential risks of alcohol during pregnancy.
A series of fact sheets have been prepared on a number of issues relating to Indigenous suicide prevention, from our investigations and roundtable discussions.
Strengthening the capacity of Aboriginal children, families and communities
Research
KAMS MOUAs part of the discussions with Kimberley Aboriginal Medical Service (KAMS) to establish the Broome site of the WAAHKN it has been agreed to establish...
Not too long ago, if you had mentioned physical activity to educators at the Sonas Early Learning & Care centres run by Shelley Prendergast, they would automatically have reached for the trusty old obstacle course.
Despite the risk of having a hypo (low blood glucose levels), Gina said she refused to let T1D stop her from exercising.
Research
Performance characteristics and potential public health impact of improved pre-erythrocytic malaria vaccines targeting childhood burdenNew malaria vaccine development builds on groundbreaking recommendations and roll-out of two approved pre-erythrocytic vaccines (PEVs); RTS,S/AS01 and R21/Matrix-M. Whilst these vaccines are effective in reducing childhood malaria within yearly routine immunization programs or seasonal vaccination, there is little evidence on how different PEV efficacies, durations of protection, and spacing between doses influence the potential to avert uncomplicated and severe childhood malaria.